Search Search by keyword Filter Diseases & Conditions — ADHDAlzheimer’s DiseaseAmyloidosisAnemia in Chronic Kidney DiseaseAsthmaAtopic DermatitisBehavioral HealthBeta ThalassemiaCancerCardiovascular DiseaseChronic PainCommunity HealthCOVID-19Cystic FibrosisDiabetesDuchenne Muscular DystrophyEndometriosisHemophilia AHepatitis CHereditary AngioedemaHypertrophic CardiomyopathyLupus NephritisMethods Update: Ultra-Rare DiseaseMethods Update: Value Assessment FrameworkMethods Update: Valuing A CureMigraineMultiple SclerosisMyasthenia GravisNASHObesity ManagementOpioid EpidemicOsteoporosisPalliative CarePeanut AllergyPolicy: Accelerated Approval PathwayPolicy: Fair AccessPolicy: Gene TherapiesPolicy: Indication Specific PricingPolicy: Real World EvidencePolicy: RebatesPolicy: Unsupported Price IncreasePsoriasisPTSD: Service DogsRetinal DiseaseRheumatoid ArthritisSickle Cell DiseaseSleep ApneaSpinal Muscular AtrophyTardive DyskinesiaUlcerative Colitis Status — Ongoing Completed Year Completed — 200720082009201020112012201320142015201620172018201920202021 Research Type — AssessmentPolicy Paper Results: Ongoing & Completed Policy Papers Strengthening the FDA’s Accelerated Approval Pathway Apr 2021 Unsupported Price Increases Occurring in 2020 Nov 2021 Unsupported Price Increases Occurring in 2019 Jan 2021 Cornerstones of ‘Fair’ Drug Coverage Sep 2020 Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19 Jul 2020 Methods Update: Value Assessment Framework Jan 2020 Unsupported Price Increases Occurring in 2017-2018 Oct 2019 Methods Update: Valuing a Cure Sep 2019 Alternative Models for Pharmaceutical Rebates Dec 2018 A Framework to Guide the Optimal Development and Use of Real World Evidence for Coverage and Formulary Decisions Dec 2017 Methods Update: Treatments for Ultra-Rare Diseases May 2017 Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value Dec 2016 Indication-specific pricing: pharmaceuticals in the United States health care system Dec 2015 Alzheimer’s Disease: Evaluating Diagnostics Dec 2012
